Analysts think TNDM stock price could decrease by -12%
Dec 08, 2025, 12:25 PM
5.11%
What does TNDM do
Tandem Diabetes Care, based in San Diego, focuses on products for insulin-dependent diabetes, employing 2,400 staff since its IPO in 2013. Its advanced insulin pumps, including the t:slim X2, feature Control-IQ technology and are compatible with various CGM sensors.
24 analysts think TNDM stock price will decrease by -12.26%. The current median analyst target is $18.36 compared to a current stock price of $20.93. The lowest analysts target is $14.14 and the highest analyst target is $57.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.